on 01 Dec 2022
Last Applicant/ Owned by
XERIS PHARMACEUTICALS INC.
180 N LaSalle Street, Suite 1810Chicago IL 60601
US
Serial Number
2126619 filed on 03rd Jun 2021
Correspondent Address
3700 CANTERRA TOWER400 - THIRD AVENUE S.W.CALGARY
ALBERTA
CA
T2P4H2
Trademark usage description
pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous syst Read More11
11
2126619
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 48 on 06th Mar 2023 | Agent Changed |
Submitted for opposition 22 on 01st Dec 2022 | Search Recorded |
Submitted for opposition 20 on 01st Dec 2022 | Examiner's First Report |
Submitted for opposition 223 on 01st Dec 2022 | Total Provisional Refusal |
Submitted for opposition 256 on 13th Jun 2022 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 12th Aug 2021 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 11th Aug 2021 | Formalized |
Submitted for opposition 1 on 11th Aug 2021 | Created |
Submitted for opposition 228 on 03rd Jun 2021 | International Registration |
Submitted for opposition 30 on 03rd Jun 2021 | Filed |